Entrada Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $42k | 7.2k | 5.80 |
| 2025-06-30 | $110k | 16k | 6.72 |
| 2025-03-31 | $148k | 16k | 9.04 |
| 2024-12-31 | $282k | 16k | 17.29 |
| 2024-09-30 | $233k | 15k | 15.98 |
| 2024-06-30 | $208k | 15k | 14.25 |
| 2023-12-31 | $177k | 12k | 15.09 |
| 2023-09-30 | $185k | 12k | 15.80 |
| 2023-06-30 | $177k | 12k | 15.14 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors